Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3879915 | The Journal of Urology | 2006 | 7 Pages |
Abstract
In light of our results we suggest that all patients with vascular invasion should receive chemotherapy. However, patients with no risk factors and those with more than 50% embryonal carcinoma but without vascular invasion should be on surveillance after orchiectomy since the relapse rate is less than 30%. Although strict followup in the first year is justified, followup schemas may be reassessed for the frequency of radiological investigations.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Rauf Taner Divrik, Bülent AkdoÄan, Haluk Ãzen, Ferruh Zorlu,